Quantcast

Latest Cancer treatments Stories

2015-02-25 08:32:41

- New, long-term preliminary data from Phase II STAND trial to be presented at 2015 Genitourinary Cancers Symposium (ASCO GU) LAVAL, Quebec, Feb.

2015-02-24 23:09:41

The Hong Kong Polytechnic University (PolyU) entered into a license agreement on 13 February 2015 with a global oncology specialist company, Kinex Pharmaceuticals, Inc.

2015-02-20 08:26:40

A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.

2015-02-19 16:30:23

NEW YORK, Feb. 19, 2015 /PRNewswire/ -- Novogen presented yesterday (Wednesday February 18) to an audience of stockholders, analysts, investors and investment bankers.

2015-02-11 08:30:57

DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/ptgkrh/drug_delivery_in)

2015-02-09 08:31:50

Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.

2015-02-05 23:01:43

Nation’s largest cancer magazine reports on beloved television host’s experiences, guidance for others. Plainsboro, NJ (PRWEB) February 05, 2015

2015-02-05 08:32:37

LUGANO, Switzerland and COPENHAGEN, Denmark, February 5, 2015 /PRNewswire/ -- - Elsiglutide is a GLP-2 receptor agonist with potential as a first-ever therapy to help cancer

2015-02-04 23:08:55

New guidebook helps patients, doctors come together to make most of available treatment options. MADISON, Wisc.


Word of the Day
dwale
  • The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
  • A sleeping-potion; a soporific.
  • To mutter deliriously.
The word 'dwale' comes from an Old English word meaning 'error, doubt, delusion.'
Related